Public annual accounts

LEORAPH financials

Name: LEORAPH financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for LEORAPH, with comparable measures and links to available source documents.

Company overview

Registry number

0693680652

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for LEORAPH

2025 versus 2024

Operating line: €13,346
EBITDA: €13,112
Total assets: €248,134
Equity: €229,624

EBITDA margin +98.2% · Equity ratio +92.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€13,346	€13,112	€248,134	€229,624	-
202430 Jun 2024	€9,651	€9,602	€241,586	€224,896	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report